Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Oct 11, 2020
Date Accepted: May 3, 2021
Text4Heart II; Improving medication adherence in people with heart disease: A randomized controlled trial
ABSTRACT
Background:
Mobile health technologies offer potential to improve reach and delivery of interventions to promote long-term secondary prevention of coronary heart disease (CHD).
Objective:
To determine the effectiveness of a text-messaging intervention (Text4HeartII) to improve adherence to medication and lifestyle change over and above usual care in people with CHD.
Methods:
A two-arm, parallel, randomized controlled trial conducted in New Zealand. Participants with a recent acute coronary syndrome were randomised to receive usual cardiac services alone (control n=153) or a 24-week text message programme to support self-management plus usual cardiac services (n=153). The primary outcome was adherence with medication at 24-weeks, defined as medication possession ratio (MPR) of 80% or more for aspirin, statin and anti-hypertensive therapy. Secondary outcomes included MPR at 52-weeks, self-reported medication adherence, and adherence with healthy lifestyle behaviours at 24- and 52-weeks.
Results:
National hospitalization and pharmacy dispensing records were available for all participants; 282 (92%) completed 24-weeks questionnaire and 291 (95%) completed 52-weeks questionnaire. Adherence with 3 medication classes was greater in the control compared to the intervention group, respectively both at 24-weeks (105(69%) versus 87(57%) OR 0.60, 95%CI 0.38 to 0.96, p=0.03), and 52 weeks (104(68%) vs 83(53%) OR 0.56, 95%CI 0.35 to 0.89, p=0.01). Self-reported medication adherence score showed the same trend at 52 weeks (mean difference 0.3, 95%CI 0.01 to 0.59, p=0.04). Self-reported adherence with health related behaviours were similar between groups.
Conclusions:
Text4HeartII did not improve dispensed medication, or adherence to a favorable lifestyle over and above usual care. This finding contrasts with previous studies, and highlights that the benefits of text interventions may depend on the context in which they are used. Clinical Trial: Australian New Zealand Clinical Trials Registry, ID: ACTRN12616000422426
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.